Pharma layoffs in 2025 have surged, with thousands facing job cuts as companies like BMS and Novartis streamline operations.

It wasn’t always this way. Leveraging AI in drug development is not only thanks to growing access to semiconductor chips, but ...

We recently published 10 Stocks Crash as AI Glow Fades. Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of Wednesday’s worst performers. Recursion Pharmaceuticals dropped for a third straight day ...

One person that helped bring the chill was an analyst cutting his price target. Another two were executives at the biotech selling chunks of stock. The company was the target of an analyst price ...

Explore ARKG for active exposure to innovative genomics stocks. Understand its high growth potential, volatility, and key ...

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

Francesco Catanzariti has spent his first year as a new analyst at Balyasny in a volatile market. He spoke to BI about what it's been like to start his career at a hedge fund in this environment. From ...

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of Wednesday’s worst performers. Recursion Pharmaceuticals dropped for a third straight day on Wednesday, slashing 6.29 percent to close at $4.77 ...

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of the 10 Best Penny Stocks to Buy for the Next 5 Years. On August 5, Needham reiterated its Buy rating on Recursion Pharmaceuticals, Inc.

Pharah is one of the most popular heroes in Overwatch 2, and her Stadium powers make her much more enjoyable to play. With increased fuel capacity, homing rockets, and increased Ultimate power, you ...

I seem to be having a very different experience with GPT-5, the newest iteration of OpenAI’s flagship model, from most everyone else. The commentariat consensus is that GPT-5 is a dud, a ...